Cantor Fitzgerald Predicts JSPR FY2026 Earnings
Jasper Therapeutics, Inc. (NASDAQ:JSPR – Free Report) – Equities research analysts at Cantor Fitzgerald issued their FY2026 EPS estimates for shares of Jasper Therapeutics in a note issued to investors on Monday, June 9th. Cantor Fitzgerald analyst P. Stavropoulos forecasts that the company will post earnings of ($3.96) per share for the year. The consensus […]
Jasper Therapeutics, Inc. (NASDAQ:JSPR – Free Report) – Equities research analysts at Cantor Fitzgerald issued their FY2026 EPS estimates for shares of Jasper Therapeutics in a note issued to investors on Monday, June 9th. Cantor Fitzgerald analyst P. Stavropoulos forecasts that the company will post earnings of ($3.96) per share for the year. The consensus […]
